Tregs are a subset of CD4+ immune T cells that, in physiological conditions, guarantee tolerance to self-antigens and prevent/suppress autoimmune reactions, while, in cancer, they supply tumor progression and tumorigenesis by impairing host immune defenses. Here, CD4 is linked to neoplasm.